HomeNewsBusinessEconomyLast tranche of stimulus package offers succour to India Inc; props up healthcare and education

Last tranche of stimulus package offers succour to India Inc; props up healthcare and education

No fresh insolvency to be initiated for a year; COVID-19 related debt to be excluded from definition of default.

May 17, 2020 / 15:19 IST
Story continues below Advertisement

On the last day of stimulus package announcements, FM Nirmala Sitharaman on May 17 unveiled a set of measures expected to give India Inc some breathing space amid the COVID-19 disruption.

The seven areas in focus in today's announcements were MGNREGA, healthcare and education, business during COVID-19, decrimilisation of Companies Act, Ease of Doing Business, PSUs and state government and resources.

Story continues below Advertisement

Before unveiling the measures, Sitharaman outlined the measures taken by the Modi government to mitigate the hardships faced by citizens due to the lockdown measures.

"Around 20 crore Jan Dhan account holders have got a total of Rs.10,000 crore as of May 16. All the payments under PM Garib Kalyan Yojana were done online and was possible only because of the DBT system developed in the last four years. 6.81 crore people got free LPG cylinders and 12 lakh EPFO holders got online withdrawal of advance," Sitharaman said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show